Home > Drug List > Cobimetinib > News of Cobimetinib

News of Cobimetinib

Cobimetinib was first approved for marketing in the United States in 2015, and the latest revised version was updated in May 2023.

Cobimetinib

Cobimetinib

Indications： This product is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations (in combination with vemurafenib), as well as for the mon

Scan code
Whatsapp

Medicine-related columns

Recommended Articles

Related Articles

There is no data under this category！
Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Hospital Departments
Latest Articles
Medicine Updates

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Product

Product

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

whatsapp